Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults

Arthritis and Rheumatology

Volumn 66, Issue 8, 2014, Pages 2297-2307

  Kumakura, Shunichi ^a   Murakawa, Yohko ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904992221     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38672     Document Type: Article

References (50)

1. Janka GE, Schneider EM,. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004; 124: 4-14.
2. Gupta S, Weitzman S,. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 2010; 6: 137-54.
3. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957-9.
4. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003; 115: 461-73.
5. Zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005; 14: 827-34.
6. Zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009; 85: 482-92.
7. Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000; 25: 173-6.
8. Barbosa MD, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996; 382: 262-5.
9. Jung J, Bohn G, Allroth A, Boztug K, Brandes G, Sandrock I, et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood 2006; 108: 362-9.
10. Hadchouel M, Prieur AM, Griscelli C,. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985; 106: 561-6.
11. Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM,. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993; 11: 451-6.
12. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY,. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991; 114: 387-90.
13. Kumakura S, Ishikura H, Endo J, Kobayashi S,. Autoimmune-associated hemophagocytosis. Am J Hematol 1995; 50: 148-9.
14. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S,. Autoimmune-associated hemophagocytic syndrome. Am J Med 1997; 102: 113-5.
15. Kumakura S, Ishikura H, Munemasa S, Adachi T, Murakawa Y, Kobayashi S,. Adult onset Still's disease-associated hemophagocytosis. J Rheumatol 1997; 24: 1645-8.
16. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Kobayashi S,. Hemophagocytosis associated with MPO-ANCA positive vasculitis in systemic sclerosis. Clin Exp Rheumatol 2002; 20: 411-4.
17. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S,. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 2004; 14: 205-15.
18. Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine (Baltimore) 2006; 85: 169-82.
19. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007; 86: 58-65.
20. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
22. Bohan A, Peter JB,. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
23. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
24. Alarcon-Segovia D, Villareal M,. Classification and diagnosis criteria for mixed connective tissue disease. In:, Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science; 1987. p. 33-40.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
26. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum 1990; 33: 1065-7.
27. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93.
28. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al, and the European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996; 55: 116-21.
29. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002; 61: 554-8.
30. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424-30.
31. Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002; 81: 194-200.
32. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM,. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 1285-92.
33. Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009; 60: 3388-99.
34. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308.
35. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore) 2004; 83: 1-17.
36. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-11.
37. Duarte Couto M, Ines L, Liang MH,. Epidemiology of systemic lupus erythematosus. In:, Lahita RG, Tsokos G, Buyon J, Koike T, editors. Systemic lupus erythematosus. 5th ed. Philadelphia: Elsevier; 2011. p. 673-96.
38. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM,. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007; 56: 2092-4.
39. Lahita RG,. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-6.
40. Nossent JC,. Adult-onset Still's disease. In:, Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th ed. Philadelphia: Elsevier; 2011. p. 849-58.
41. Schur PH,. Laboratory evaluation of patients with systemic lupus erythematosus. In:, Lahita RG, Tsokos G, Buyon J, Koike T, editors. Systemic lupus erythematosus. 5th ed. Philadelphia: Elsevier; 2011. p. 629-53.
42. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993-1002.
43. Favara BE,. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992; 9: 63-74.
44. Tsuda H,. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 1997; 65: 215-26.
45. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31.
46. Sawhney S, Woo P, Murray KJ,. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-6.
47. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM,. Efficacy of cyclosporine A in the treatment of MAS in juvenile arthritis: report of five cases. J Pediatr 1996; 129: 750-4.
48. Ravelli A, de Benedetti F, Viola S, Martini A,. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 128: 275-8.
49. Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG,. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease. Arthritis Rheum 2010; 62: 2530-5.
50. Lehmberg K, Ehl S,. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol 2013; 160: 275-87.